Education
About Us
Working with TipRanks
Follow Us
Aethlon Medical Inc (AEMD)
NASDAQ:AEMD
Total Valuation
Aethlon Medical has a market cap or net worth of $3.02M. The enterprise value is -$4.85B.
Market Cap$3.02M
Enterprise Value-$4.85B
Share Statistics
Aethlon Medical has 2,585,316 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,585,316
Owned by Insiders43.45%
Owned by Institutions19.30%
Financial Efficiency
Aethlon Medical’s return on equity (ROE) is -2.61 and return on invested capital (ROIC) is 0.00%.
Return on Equity (ROE)-2.61
Return on Assets (ROA)-1.82
Return on Invested Capital (ROIC)0.00%
Return on Capital Employed (ROCE)0.00
Revenue Per Employee0.00
Profits Per Employee-956.29M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aethlon Medical is >-0.01. Aethlon Medical’s PEG ratio is <0.01.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio<0.01
Income Statement
In the last 12 months, Aethlon Medical had revenue of 0.00 and earned -13.39B in profits. Earnings per share was -8.58.
Revenue0.00
Gross Profit0.00
Operating Income0.00
Pretax Income-13.39B
Net Income-13.39B
EBITDA0.00
Earnings Per Share (EPS)-8.58
Cash Flow
In the last 12 months, operating cash flow was -7.65B and capital expenditures 0.00, giving a free cash flow of -7.65B billion.
Operating Cash Flow-7.65B
Free Cash Flow-7.65B
Free Cash Flow per Share-2.96K
Dividends & Yields
Aethlon Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.10
52-Week Price Change-64.16%
50-Day Moving Average2.52
200-Day Moving Average3.50
Relative Strength Index (RSI)29.55
Average Volume (3m)190.55K
Important Dates
Aethlon Medical upcoming earnings date is Aug 6, 2025, After Close (Confirmed).
Last Earnings DateJun 26, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
Aethlon Medical as a current ratio of 3.13, with Debt / Equity ratio of 12.68%
Current Ratio3.13
Quick Ratio3.13
Debt to Market Cap145.54
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Aethlon Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Aethlon Medical EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 0.63.
EV to Sales0.00
EV to EBITDA0.00
EV to Free Cash Flow0.63
EV to Operating Cash Flow0.63
Balance Sheet
Aethlon Medical has $5.50B in cash and marketable securities with $649.75M in debt, giving a net cash position of -$4.85B billion.
Cash & Marketable Securities$5.50B
Total Debt$649.75M
Net Cash-$4.85B
Net Cash Per Share-$1.88K
Tangible Book Value Per Share$3.28K
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aethlon Medical is $3.25, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$3.25
Price Target Upside177.78% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast-100.00%
EPS Growth Forecast68.26%